Emma Sandén

Associate Researcher
More filtering options
  1. 2017
  2. Establishment and characterization of an orthotopic patient-derived Group 3 medulloblastoma model for preclinical drug evaluation

    Emma Sandén, Dyberg, C., Krona, C., Gallo-Oller, G., Olsen, T. K., Julio Enríquez Pérez, Wickström, M., Estekizadeh, A., Kool, M., Visse, E., Ekström, T. J., Peter Siesjö, Inge Johnsen, J. & Anna Darabi, 2017 Apr 18, In : Scientific Reports. 7, 46366.

    Research output: Contribution to journalArticle

  3. 2016
  4. Experimental models of pediatric brain tumors. Establishment, immunophenotyping and clinical implications.

    Emma Sandén, 2016, Lund: Lund University, Faculty of Medicine. 110 p.

    Research output: ThesisDoctoral Thesis (compilation)

  5. 2015
  6. Aberrant immunostaining pattern of the CD24 glycoprotein in clinical samples and experimental models of pediatric medulloblastomas.

    Emma Sandén, Dyberg, C., Krona, C., Visse, E., Carén, H., Northcott, P. A., Kool, M., Nils Ståhl, Persson, A., Elisabet Englund, Johnsen, J. I., Peter Siesjö & Anna Darabi, 2015, In : Journal of Neurooncology. 123, 1, p. 1-13

    Research output: Contribution to journalArticle

  7. Wnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance.

    Wickström, M., Dyberg, C., Milosevic, J., Einvik, C., Calero, R., Sveinbjörnsson, B., Emma Sandén, Anna Darabi, Peter Siesjö, Kool, M., Kogner, P., Baryawno, N. & Johnsen, J. I., 2015, In : Nature Communications. 6, 8904.

    Research output: Contribution to journalArticle

  8. 2014
  9. Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma.

    Northcott, P. A., Lee, C., Zichner, T., Stütz, A. M., Erkek, S., Kawauchi, D., Shih, D. J. H., Hovestadt, V., Zapatka, M., Sturm, D., Jones, D. T. W., Kool, M., Remke, M., Cavalli, F. M. G., Zuyderduyn, S., Bader, G. D., VandenBerg, S., Esparza, L. A., Ryzhova, M., Wang, W. & 59 othersWittmann, A., Stark, S., Sieber, L., Seker-Cin, H., Linke, L., Kratochwil, F., Jäger, N., Buchhalter, I., Imbusch, C. D., Zipprich, G., Raeder, B., Schmidt, S., Diessl, N., Wolf, S., Wiemann, S., Brors, B., Lawerenz, C., Eils, J., Warnatz, H-J., Risch, T., Yaspo, M-L., Weber, U. D., Bartholomae, C. C., von Kalle, C., Turányi, E., Hauser, P., Emma Sandén, Anna Darabi, Peter Siesjö, Sterba, J., Zitterbart, K., Sumerauer, D., van Sluis, P., Versteeg, R., Volckmann, R., Koster, J., Schuhmann, M. U., Ebinger, M., Grimes, H. L., Robinson, G. W., Gajjar, A., Mynarek, M., von Hoff, K., Rutkowski, S., Pietsch, T., Scheurlen, W., Felsberg, J., Reifenberger, G., Kulozik, A. E., von Deimling, A., Witt, O., Eils, R., Gilbertson, R. J., Korshunov, A., Taylor, M. D., Lichter, P., Korbel, J. O., Wechsler-Reya, R. J. & Pfister, S. M., 2014, In : Nature. 511, 7510, p. 428

    Research output: Contribution to journalArticle

  10. Intratumoral COX-2 inhibition enhances GM-CSF immunotherapy against established mouse GL261 brain tumors.

    Eberstål, S., Emma Sandén, Fritzell, S., Anna Darabi, Visse, E. & Peter Siesjö, 2014, In : International Journal of Cancer. 134, 11, p. 2748-2753

    Research output: Contribution to journalArticle

  11. 2013
  12. Aluminium based adjuvants and their effects on mitochondria and lysosomes of phagocytosing cells

    Ohlsson, L., Exley, C., Anna Darabi, Emma Sandén, Peter Siesjö & Eriksson, H., 2013, In : Journal of Inorganic Biochemistry. 128, p. 229-236

    Research output: Contribution to journalArticle

  13. IFNγ in combination with IL-7 enhances immunotherapy in two rat glioma models.

    Fritzell, S., Eberstål, S., Emma Sandén, Visse, E., Anna Darabi & Peter Siesjö, 2013, In : Journal of Neuroimmunology. 258, 1-2, p. 91-95

    Research output: Contribution to journalArticle

  14. Intratumoral temozolomide synergizes with immunotherapy in a T cell-dependent fashion.

    Fritzell, S., Emma Sandén, Eberstål, S., Visse, E., Anna Darabi & Peter Siesjö, 2013, In : Cancer Immunology and Immunotherapy. 62, 9, p. 1463-1474

    Research output: Contribution to journalArticle

  15. 2012
  16. ANALYSIS OF CLUSTER OF DIFFERENTIATION (CD) MARKERS IN PEDIATRIC BRAIN TUMORS CAN BE USED AS A DIAGNOSTIC AND PROGNOSTIC TOOL

    Emma Sandén, Visse, E., Peter Siesjö & Anna Darabi, 2012 Jun 14, In : Neuro-Oncology. 14, suppl. 1, p. i43-i48

    Research output: Contribution to journalPublished meeting abstract